Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 32093-35-9
2. (s)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole Phosphate
3. Fig89n8azy
4. (-)-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazole Phosphate
5. (6s)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;phosphoric Acid
6. Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (s)-, Phosphate (1:1)
7. (s)-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazoletriylium Phosphate
8. Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (s)-, Phosphate(1:1)
9. Einecs 250-920-3
10. Unii-fig89n8azy
11. Levamisole Phosphate, Usp
12. Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, Phosphate (1:1), (-)-
13. Schembl675957
14. Dtxsid90185890
15. Akos015951285
16. Levamisole Phosphate [green Book]
17. Q27278002
18. (s)-6-phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]thiazole Phosphate
| Molecular Weight | 302.29 g/mol |
|---|---|
| Molecular Formula | C11H15N2O4PS |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 1 |
| Exact Mass | 302.04901514 g/mol |
| Monoisotopic Mass | 302.04901514 g/mol |
| Topological Polar Surface Area | 119 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 296 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A Levamisole Phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levamisole Phosphate, including repackagers and relabelers. The FDA regulates Levamisole Phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levamisole Phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Levamisole Phosphate supplier is an individual or a company that provides Levamisole Phosphate active pharmaceutical ingredient (API) or Levamisole Phosphate finished formulations upon request. The Levamisole Phosphate suppliers may include Levamisole Phosphate API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levamisole Phosphate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levamisole Phosphate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levamisole Phosphate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levamisole Phosphate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levamisole Phosphate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levamisole Phosphate suppliers with NDC on PharmaCompass.
Levamisole Phosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Levamisole Phosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Levamisole Phosphate GMP manufacturer or Levamisole Phosphate GMP API supplier for your needs.
A Levamisole Phosphate CoA (Certificate of Analysis) is a formal document that attests to Levamisole Phosphate's compliance with Levamisole Phosphate specifications and serves as a tool for batch-level quality control.
Levamisole Phosphate CoA mostly includes findings from lab analyses of a specific batch. For each Levamisole Phosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Levamisole Phosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Levamisole Phosphate EP), Levamisole Phosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Levamisole Phosphate USP).
LOOKING FOR A SUPPLIER?
